These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 19062016)

  • 1. Osteoprotegerin as an independent marker of subclinical atherosclerosis in osteoporotic postmenopausal women.
    Shargorodsky M; Boaz M; Luckish A; Matas Z; Gavish D; Mashavi M
    Atherosclerosis; 2009 Jun; 204(2):608-11. PubMed ID: 19062016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased augmentation index and central aortic blood pressure in osteoporotic postmenopausal women.
    Mangiafico RA; Alagona C; Pennisi P; Parisi N; Mangiafico M; Purrello F; Fiore CE
    Osteoporos Int; 2008 Jan; 19(1):49-56. PubMed ID: 17676381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of calcification of atherosclerotic plaque and arterial stiffness to bone mineral density and osteoprotegerin in postmenopausal women referred for osteoporosis screening.
    Frost ML; Grella R; Millasseau SC; Jiang BY; Hampson G; Fogelman I; Chowienczyk PJ
    Calcif Tissue Int; 2008 Aug; 83(2):112-20. PubMed ID: 18612580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association between carotid or femoral atherosclerosis and low bone mass in postmenopausal women referred for osteoporosis screening. Does osteoprotegerin play a role?
    Pennisi P; Russo E; Gaudio A; Veca R; D'Amico F; Mangiafico RA; Laspina M; Tringali G; Signorelli SS; Fiore CE
    Maturitas; 2010 Dec; 67(4):358-62. PubMed ID: 20727694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone metabolism regulators and arterial stiffness in postmenopausal women.
    Albu A; Fodor D; Bondor C; Crăciun AM
    Maturitas; 2013 Oct; 76(2):146-50. PubMed ID: 23916080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum osteoprotegerin and osteopontin levels are associated with arterial stiffness and the presence and severity of coronary artery disease.
    Tousoulis D; Siasos G; Maniatis K; Oikonomou E; Kioufis S; Zaromitidou M; Paraskevopoulos T; Michalea S; Kollia C; Miliou A; Kokkou E; Papavassiliou AG; Stefanadis C
    Int J Cardiol; 2013 Sep; 167(5):1924-8. PubMed ID: 22640692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationships among serum receptor of nuclear factor-kappaB ligand, osteoprotegerin, high-sensitivity C-reactive protein, and bone mineral density in postmenopausal women: osteoimmunity versus osteoinflammatory.
    Nabipour I; Larijani B; Vahdat K; Assadi M; Jafari SM; Ahmadi E; Movahed A; Moradhaseli F; Sanjdideh Z; Obeidi N; Amiri Z
    Menopause; 2009; 16(5):950-5. PubMed ID: 19387415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating osteoprotegerin and asymptomatic carotid atherosclerosis in postmenopausal non diabetic women.
    Albu A; Bondor CI; Crăciun AM; Fodor D
    Adv Med Sci; 2014 Sep; 59(2):293-8. PubMed ID: 25240503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of subclinical atherosclerosis by serum osteoprotegerin in premenopausal women with systemic lupus erythematous: correlation of osteoprotegerin with monocyte chemotactic protein-1.
    Park YJ; Shin YJ; Kim WU; Cho CS
    Lupus; 2014 Mar; 23(3):236-44. PubMed ID: 24531425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating osteoprotegerin in postmenopausal osteoporotic women: marker of impaired glucose regulation or impaired bone metabolism.
    Mashavi M; Menaged M; Shargorodsky M
    Menopause; 2017 Nov; 24(11):1264-1268. PubMed ID: 28697041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum osteoprotegerin level, carotid-femoral pulse wave velocity and cardiovascular survival in haemodialysis patients.
    Speer G; Fekete BC; El Hadj Othmane T; Szabó T; Egresits J; Fodor E; Kiss I; Logan AG; Nemcsik J; Szabó A; Németh ZK; Szathmári M; Tislér A
    Nephrol Dial Transplant; 2008 Oct; 23(10):3256-62. PubMed ID: 18450827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arterial stiffness and novel biomarkers in patients with abdominal aortic aneurysms.
    Kadoglou NP; Papadakis I; Moulakakis KG; Ikonomidis I; Alepaki M; Moustardas P; Lampropoulos S; Karakitsos P; Lekakis J; Liapis CD
    Regul Pept; 2012 Nov; 179(1-3):50-4. PubMed ID: 22982141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association of serum osteoprotegerin and osteoporosis in postmenopausal hemodialysis patients: a pilot study.
    Wu WT; Lee RP; Wang CH; Fang TC; Lin NT; Chen IH; Hsu BG
    J Womens Health (Larchmt); 2010 Apr; 19(4):785-90. PubMed ID: 20210559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of serum osteoprotegerin with arterial stiffness, preclinical atherosclerosis, and disease activity in patients with ankylosing spondylitis.
    Serdaroğlu Beyazal M; Erdoğan T; Türkyılmaz AK; Devrimsel G; Cüre MC; Beyazal M; Sahin I
    Clin Rheumatol; 2016 Sep; 35(9):2235-41. PubMed ID: 26847856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adiponectin is better predictor of subclinical atherosclerosis than liver function tests in patients with nonalcoholic fatty liver disease.
    Omelchenko E; Gavish D; Shargorodsky M
    J Am Soc Hypertens; 2014 Jun; 8(6):376-80. PubMed ID: 24794207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum homocysteine, folate, vitamin B12 levels and arterial stiffness in diabetic patients: which of them is really important in atherogenesis?
    Shargorodsky M; Boaz M; Pasternak S; Hanah R; Matas Z; Fux A; Beigel Y; Mashavi M
    Diabetes Metab Res Rev; 2009 Jan; 25(1):70-5. PubMed ID: 19065546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between serum levels of vascular calcification inhibitors and carotid plaque vulnerability.
    Kadoglou NP; Gerasimidis T; Golemati S; Kapelouzou A; Karayannacos PE; Liapis CD
    J Vasc Surg; 2008 Jan; 47(1):55-62. PubMed ID: 18178454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationships between serum osteoprotegerin, matrix metalloproteinase-2 levels and bone metabolism in postmenopausal women.
    Dai Y; Shen L
    Chin Med J (Engl); 2007 Nov; 120(22):2017-21. PubMed ID: 18067789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating osteoprotegerin is associated with age and systolic blood pressure, but not with lipid profile or fasting glucose, in postmenopausal women.
    Uemura H; Yasui T; Miyatani Y; Yamada M; Hiyoshi M; Arisawa K; Irahara M
    Menopause; 2008; 15(1):180-4. PubMed ID: 17545921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of alendronate treatment on serum levels of osteoprotegerin and total receptor activator of nuclear factor kappaB in women with postmenopausal osteoporosis.
    Reyes-García R; Muñoz-Torres M; García DF; Mezquita-Raya P; García Salcedo JA; de Dios Luna J
    Menopause; 2010; 17(1):140-4. PubMed ID: 19574937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.